Riviciclib

A novel potent CDK inhibitor with IC50 of 79 nM, 63 nM and 20 nM for Cdk4/cyclin D1, Cdk1/cyclin B and Cdk9/cyclin T1, respectively.

920113-03-7

≥ 2 years

>98% (HPLC)

438.3

C21H20ClNO5.HCl

Research use only, not for human use.

CDK1/CyclinB| CDK2/CyclinA| CDK4/CyclinD1| CDK6/CyclinD3| CDK9/CyclinT1

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP2-77727 5 Slides

Ask

abx190171-01 96 Tests

Ask

abx190171-02 5x 96 Tests

Ask

abx190171-03 10x 96 Tests

Ask

MBS2158387-01 96 Tests

Ask

MBS2158387-02 5x 96 Tests

Ask